Back to Search Start Over

Benign and malignant proliferation in idiopathic nephrotic syndrome: a French cohort study.

Authors :
Cébron C
Godron-Dubrasquet A
Aladjidi N
Roussey G
Boyer O
Avramescu M
Baudouin V
Terzic J
Allain-Launay E
Rieux-Laucat F
Decramer S
Simon T
Harambat J
Source :
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2022 Aug; Vol. 37 (8), pp. 1837-1843. Date of Electronic Publication: 2022 Jan 10.
Publication Year :
2022

Abstract

Background: There seems to be a possible link between nephrotic syndrome (NS) and lymphoproliferative syndrome, but it remains poorly understood.<br />Methods: This multicentric and retrospective study focuses on children, who developed idiopathic NS and malignant or benign proliferation between 2000 and 2021.<br />Results: Eleven patients were included, with a median age of 4 years. Only one had a steroid-resistant nephrotic syndrome (SRNS). The maintenance therapy before the proliferation was in majority tacrolimus or mycophenolate mofetil (MMF), but three patients did not receive treatments. The proliferation was mainly a Hodgkin's lymphoma (45%) or a lymphoproliferative disease (36%), in a median time after the NS of two years. Viruses were found in seven cases (EBV in five cases and HHV-8 in two).<br />Conclusion: The association between proliferative syndrome and idiopathic NS may not be fortuitous, possibly with a common lymphocytic disturbance. Genetic analyses could improve the comprehension of these manifestations in the future. A higher resolution version of the Graphical abstract is available as Supplementary information.<br /> (© 2021. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)

Details

Language :
English
ISSN :
1432-198X
Volume :
37
Issue :
8
Database :
MEDLINE
Journal :
Pediatric nephrology (Berlin, Germany)
Publication Type :
Academic Journal
Accession number :
35006357
Full Text :
https://doi.org/10.1007/s00467-021-05386-0